Company
Transposon Therapeutics
Transformational therapies for neurodegenerative and aging-related diseases
Also known as Transposon Therapeutics, Inc.
- Status
- Operatingas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Transposon Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Transposon Therapeutics is a startup focused on transformational therapies for neurodegenerative and aging-related diseases. Its focus includes neurodegenerative diseases and aging-related diseases.
Funding snapshot
- Total raised
- $59.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $4.7M2024-07-10
Funding rounds
- Round, 2024
- $4.7M2024-07-10, SEC form D sold, 8 investors
- Round, 2022
- $5M2022-12-20, SEC form D sold, 8 investors
- Round, 2020
- $45.2M2020-11-25, SEC form D sold, 10 investors
- Round, 2020
- $4.2M2020-04-21, SEC form D sold, 4 investors
Loading relationship preview